World Malayalee Pharma

Tag: Paragraph IV certification

FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage

FDA's 180-Day Exclusivity: How First Generic Applicants Gain Market Advantage

Maddie Shepherd Dec 8 10 Comments

FDA's 180-day exclusivity gives the first generic drug applicant a head start on the market, but it's often used to delay competition. Learn how it works, who benefits, and why reforms are coming.

More Detail

Recent posts

How Exercise Improves Hyperprolactinaemia Symptoms
How Exercise Improves Hyperprolactinaemia Symptoms

October 17 2025

Thalidomide and Teratogenic Medications: History, Risks, and Safety Lessons
Thalidomide and Teratogenic Medications: History, Risks, and Safety Lessons

May 18 2026

Tamoxifen vs Aromatase Inhibitors: Choosing the Right Hormone Therapy for Breast Cancer
Tamoxifen vs Aromatase Inhibitors: Choosing the Right Hormone Therapy for Breast Cancer

June 15 2026

Asthma-Allergy Overlap: How to Manage Airway Inflammation When Allergies Trigger Your Asthma
Asthma-Allergy Overlap: How to Manage Airway Inflammation When Allergies Trigger Your Asthma

November 17 2025

FDA Inspection of Generic Manufacturing Facilities: What to Expect
FDA Inspection of Generic Manufacturing Facilities: What to Expect

February 10 2026

Tags

online pharmacy
generic drugs
online pharmacy safety
Hatch-Waxman Act
medication safety
medication side effects
drug safety
patient safety
bioequivalence
drug interactions
dosage
antibiotics
insulin resistance
cardiovascular risk
medication errors
generic substitution
FDA approval
medication adherence
therapeutic equivalence
blood sugar support

About Us

Health

bg-footer

About Us

Health

Menu
About Terms Privacy Policy GDPR Compliance Contact Us
© 2026. All rights reserved.